The global point-of-care biosensors market size accounted for USD 83.65 billion in 2024, grew to USD 90.65 billion in 2025 and is projected to surpass around USD 186.71 billion by 2034, representing a healthy CAGR of 8.36% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Point-of-care Biosensors Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Point-of-care Biosensors Market Revenue and Volume, by Product, 2024-2034
8.1.1. Glucose Monitoring
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. HIV
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Hepatitis C
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. Pregnancy
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Point-of-care Biosensors Market Revenue and Volume, by Platforms, 2024-2034
9.1.1. Microfluidics
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Dipsticks
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Immunoassays
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Point-of-care Biosensors Market Revenue and Volume, by Purchase, 2024-2034
10.1.1. OTC
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Prescription
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
11.1. Point-of-care Biosensors Market Revenue and Volume, by Sample, 2024-2034
11.1.1. Blood
11.1.1.1. Market Revenue and Volume Forecast (2021-2034)
11.1.2. Urine
11.1.2.1. Market Revenue and Volume Forecast (2021-2034)
12.1. Point-of-care Biosensors Market Revenue and Volume, by End User, 2024-2034
12.1.1. Pharmacy
12.1.1.1. Market Revenue and Volume Forecast (2021-2034)
12.1.2. Hospital
12.1.2.1. Market Revenue and Volume Forecast (2021-2034)
12.1.3. Homecare
12.1.3.1. Market Revenue and Volume Forecast (2021-2034)
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.1.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.1.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.1.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.1.5. Market Revenue and Volume Forecast, by End User (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.1.6.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.1.6.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.1.6.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.1.6.5. Market Revenue and Volume Forecast, by End User (2021-2034)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.1.7.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.1.7.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.1.7.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.1.7.5. Market Revenue and Volume Forecast, by End User (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.2.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.2.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.2.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.2.5. Market Revenue and Volume Forecast, by End User (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.2.6.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.2.6.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.2.7. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.2.8. Market Revenue and Volume Forecast, by End User (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.2.9.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.2.9.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.2.10. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.2.11. Market Revenue and Volume Forecast, by End User (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.2.12.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.2.12.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.2.12.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.2.13. Market Revenue and Volume Forecast, by End User (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.2.14.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.2.14.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.2.14.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.2.15. Market Revenue and Volume Forecast, by End User (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.3.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.3.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.3.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.3.5. Market Revenue and Volume Forecast, by End User (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.3.6.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.3.6.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.3.6.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.3.7. Market Revenue and Volume Forecast, by End User (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.3.8.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.3.8.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.3.8.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.3.9. Market Revenue and Volume Forecast, by End User (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.3.10.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.3.10.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.3.10.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.3.10.5. Market Revenue and Volume Forecast, by End User (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.3.11.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.3.11.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.3.11.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.3.11.5. Market Revenue and Volume Forecast, by End User (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.4.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.4.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.4.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.4.5. Market Revenue and Volume Forecast, by End User (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.4.6.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.4.6.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.4.6.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.4.7. Market Revenue and Volume Forecast, by End User (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.4.8.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.4.8.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.4.8.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.4.9. Market Revenue and Volume Forecast, by End User (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.4.10.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.4.10.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.4.10.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.4.10.5. Market Revenue and Volume Forecast, by End User (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.4.11.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.4.11.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.4.11.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.4.11.5. Market Revenue and Volume Forecast, by End User (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.5.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.5.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.5.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.5.5. Market Revenue and Volume Forecast, by End User (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.5.6.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.5.6.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.5.6.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.5.7. Market Revenue and Volume Forecast, by End User (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)
13.5.8.2. Market Revenue and Volume Forecast, by Platforms (2021-2034)
13.5.8.3. Market Revenue and Volume Forecast, by Purchase (2021-2034)
13.5.8.4. Market Revenue and Volume Forecast, by Sample (2021-2034)
13.5.8.5. Market Revenue and Volume Forecast, by End User (2021-2034)
14.1. Abaxis
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Abbott Laboratories
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Accubiotech Co, Ltd.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. ACON Laboratories, Inc
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Becton, Dickinson and Company
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Biolytical Laboratories
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Danaher Corporation (HemoCue)
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Siemens Healthineers
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Meridian Bioscience, Inc
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample